Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALStandard

DESONIDE

DESONIDE

Standard Dose
0.05%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview DESONIDE is listed in Drugs@FDA under application 017426 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient DESONIDE Form and strength OINTMENT;TOPICAL - 0.05% Sponsor PADAGIS US Submission history Latest submission status date: 2016-06-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview DESONIDE is listed in Drugs@FDA under application 017426 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DESONIDE Form and strength OINTMENT;TOPICAL - 0.05% Sponsor PADAGIS US Submission history Latest submission status date: 2016-06-08 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.